Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP308627.RAVih-efjAbWWjIfrmRqNM2T3unc2wJKJoU84g1vmvCI4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP308627.RAVih-efjAbWWjIfrmRqNM2T3unc2wJKJoU84g1vmvCI4130_assertion type Assertion NP308627.RAVih-efjAbWWjIfrmRqNM2T3unc2wJKJoU84g1vmvCI4130_head.
- NP308627.RAVih-efjAbWWjIfrmRqNM2T3unc2wJKJoU84g1vmvCI4130_assertion description "[Since lung cancer patients were recruited mostly among smokers, who also have been found to exhibit significantly higher infection rate of Helicobacter pylori (HP) infection than non-smokers and, as since the HP-infected subjects show enhanced plasma levels of gastrin, we decided 1) to compare the seroprevalence of HP and the expression of its cytotoxin, CagA, in lung cancer patients with those in the age- and gender-matched controls without cancer: 2) to determine the gene expression for gastrin and its receptors (CCKB-R) in lung cancer, 3) to assess the gastrin levels in plasma bronchial lavage and in tumor tissue and 4) to examine the expression of cyclooxygenase (COX)-1 and COX-2 in cancer tissue resection margin and intact bronchial mucosa.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP308627.RAVih-efjAbWWjIfrmRqNM2T3unc2wJKJoU84g1vmvCI4130_provenance.
- NP308627.RAVih-efjAbWWjIfrmRqNM2T3unc2wJKJoU84g1vmvCI4130_assertion evidence source_evidence_literature NP308627.RAVih-efjAbWWjIfrmRqNM2T3unc2wJKJoU84g1vmvCI4130_provenance.
- NP308627.RAVih-efjAbWWjIfrmRqNM2T3unc2wJKJoU84g1vmvCI4130_assertion SIO_000772 11208460 NP308627.RAVih-efjAbWWjIfrmRqNM2T3unc2wJKJoU84g1vmvCI4130_provenance.
- NP308627.RAVih-efjAbWWjIfrmRqNM2T3unc2wJKJoU84g1vmvCI4130_assertion wasDerivedFrom befree-2016 NP308627.RAVih-efjAbWWjIfrmRqNM2T3unc2wJKJoU84g1vmvCI4130_provenance.
- NP308627.RAVih-efjAbWWjIfrmRqNM2T3unc2wJKJoU84g1vmvCI4130_assertion wasGeneratedBy ECO_0000203 NP308627.RAVih-efjAbWWjIfrmRqNM2T3unc2wJKJoU84g1vmvCI4130_provenance.